PharmaCyte Biotech, Inc.
Biotechnology company · Las Vegas, Nevada, United States · Nasdaq: PMCB
PharmaCyte Biotech, Inc. is a biotechnology company headquartered in Las Vegas, Nevada, United States. Its shares trade on Nasdaq under the ticker PMCB. It has reported private securities offerings to the US SEC, most recently $7 million sold in a notice filed in 2025.
PharmaCyte Biotech at a glance
What does PharmaCyte Biotech do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $7 million sold (2025).
Frequently asked questions about PharmaCyte Biotech
Where is PharmaCyte Biotech headquartered?
PharmaCyte Biotech, Inc. is headquartered in Las Vegas, Nevada, United States.
What does PharmaCyte Biotech do?
PharmaCyte Biotech, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is PharmaCyte Biotech a public company?
Yes. PharmaCyte Biotech, Inc. trades on Nasdaq under the ticker PMCB.
Similar companies
- Heligenics, Inc.Las Vegas, Nevada, United States
- Research & Diagnostic AntibodiesLas Vegas, Nevada, United States
- Frontier Health LLCLas Vegas, Nevada, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences